Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma

Head and Neck

Volumn 28, Issue 9, 2006, Pages 842-849

  Elsheikh, Mohamed N ^a   Rinaldo, Alessandra ^b   Hamakawa, Hiroyuki ^c   Mahfouz, Magdy E ^a   Rodrigo, Juan Pablo ^d,e   Brennan, Joseph ^f   Devaney, Kenneth O ^g   Grandis, Jennifer R ^h   Ferlito, Alfio ^b  

^a TANTA UNIVERSITY   (Egypt)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c EHIME UNIVERSITY   (Japan)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^f WILFORD HALL MEDICAL CENTER   (United States)

^g Foote Health System   (United States)

^h University of Pittsburgh School of Medicine   (United States)

Author keywords

Cytokeratin; Invasion; Lymph node metastasis; Micrometastasis; Molecular analysis; Neck dissection; RT PCR; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 5; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MUCIN 1; PROTEIN P53; SQUAMOUS CELL CARCINOMA ANTIGEN;

CANCER STAGING; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DNA DETERMINATION; ECHOGRAPHY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 33748250282     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20368     Document Type: Review

References (44)

1. Wirtschafter A, Benninger MS, Moss TJ, Umiel T, Blazoff K, Worsham MJ. Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report. Arch Otolaryngol Head Neck Surg 2002;128:40-43.
2. Jose J, Coatesworth AP, MacLennan K. Cervical metastases in upper aerodigestive tract squamous cell carcinoma: histopathologic analysis and reporting. Head Neck 2003;25:194-197.
3. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896-900.
4. Byers RM, dayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999;21:499-505.
5. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-2990.
6. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999;91:1113-1124.
7. Zen H, Nakashiro K, Shintani S, Sumida T, Aramoto T, Hamakawa H. Detection of circulating cancer cells in human oral squamous cell carcinoma. Int J Oncol 2003;23:605-610.
8. Hoon DS, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-2116.
9. Okami J, Dohno K, Sakon M, et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 2000;6:2326-2332.
10. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1998;82:1419-1442.
11. Huang P, Wang J, Guo Y, Xie W. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 2003;129:192-198.
12. Becker MT, Shores CG, Yu KK, Yarbrough WG. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:21-27.
13. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.
14. Partridge M. Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Ann R Coll Surg Engl 1999;81:1-11.
15. Partridge M, Li S-R, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-2725.
16. Hamakawa H, Fukizumi M, Bao Y, et al. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clin Exp Metastasis 1999;17:593-599.
17. Cai Q, Guan C, Ren Z. Detection mucin gene in cervical lymph nodes in supraglottic cancer by reverse transcription polymerase chain reaction [in Chinese], Zhonghua Er Bi Yan Hou Ke Za Zhi 2001;36:247-249.
18. Nieuwenhuis EJ, Leemans CR, Kummer JA, Denkers F, Snow GB, Brakenhoff RH. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction. Lab Invest 2003;83:1233-1240.
19. Nieuwenhuis EJ, Jaspars LH, Castelijns JA, et al. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 2003;9;755-761.
20. Shores CG, Yin X, Funkhouser W, Yarbrough W. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:937-942.
21. Onishi A, Nakashiro K, Mihara M, et al. Basic and clinical studies on quantitative analysis of lymph node micrometastasis in oral cancer. Oncol Rep 2004;11:33-39.
22. Hamakawa H, Fukuzumi M, Bao Y, et al. Keratin mRNA for detecting micrometastasis in cervical lymph nodes of oral cancer. Cancer Lett 2000;160:115-123.
23. Elsheikh MN, Mahfouz ME, Elsheikh E. Level lib lymph nodes metastasis in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: a molecular-based study. Laryngoscope 2005;115:1636-1660.
24. Elsheikh MN, Mahfouz ME, Elsheikh E. Molecular assessment of neck dissections supports preserving level lib lymph nodes in selective neck dissection for laryngeal squamous cell carcinoma with clinically negative neck. ORL J Otorhinolaryngol Relat Spec. In press.
25. Ross GL, Shoaib T, Salim EI, et al. The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002;9:406-410.
26. Zurrida S, Mazzarol G, Galimberti V, et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol 2001;8:817-820.
27. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-569.
28. Hamakawa H, Onishi A, Sumida T, et al. Intraoperative real-time genetic diagnosis for sentinel node navigation surgery. Int J Oral Maxillofac Surg 2004;33:670-675.
29. Shinohara M, Harada T, Nakamura S, Oka M, Tashiro H. Heterotopic salivary gland tissue in lymph nodes of the cervical region. Int J Oral Maxillofac Surg 1992;21:166-171.
30. Ferris RL, Xi L, Raja S, et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res 2005;65:2147-2156.
31. Yamazaki Y, Chiba I, Hirai A, et al. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma. Head Neck 2005;27:676-681.
32. Ferlito A, Partridge M, Brennan J, Hamakawa H. Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol 2001;121:660-665.
33. Rinaldo A, Devaney KO, Ferlito A. Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec 2004;66:38-41.
34. Yoshida K, Kashima K, Suenaga S, Nomi N, Shuto J, Suzuki M. Immunohistochemical detection of cervical lymph node micrometastases from T2N0 tongue cancer. Acta Otolaryngol 2005;125:654-658.
35. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-193.
36. van Houten VM, Tabor MP, van den Brekel MW, et al. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 2000;6:3803-3816.
37. Nagler RM. Molecular aspects of oral cancer. Anticancer Res 2002;22:2977-2980.
38. Makino H, Tajiri T, Onda M, et al. Detection of lymph node micrometastasis in esophageal carcinoma. Hepatogastroenterology 2003;50:1407-1410.
39. Moll R, Zimbelmann R, Goldschmidt MD, et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993;53:75-93.
40. Kawamata H, Uchida D, Nakashiro K, et al. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. Br J Cancer 1999;80:448-452.
41. Soong R, Beyser K, Basten O, Kalbe A, Rueschoff J, Tahiti K. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin Cancer Res 2001;7:3423-3429.
42. Yun K, Merrie AE, Gunn J, Phillips LV, McCall JL. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations. J Pathol 2000;191:21-26.
43. Champelovier P, Mongelard F, Seigneurin D. CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 1999;19:2073-2078.
44. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.